Rhynchophylline Attenuates Tourette Syndrome via BDNF/NF-κB Pathway In Vivo and In Vitro
Rhynchophylline Attenuates Tourette Syndrome via BDNF/NF-κB Pathway In Vivo and In Vitro
复制标题
钩藤碱在体内和体外通过 BDNF/NF-kappa B 通路减轻抽动秽语综合征
DOI:
10.1007/s12640-019-00079-x
复制
发表时间:
2019-11-01
影响因子:
3.7
通讯作者:
Huang, Yaruo
中科院分区:
文献类型:
--
作者:
Long, Hongyan;Ruan, Jie;Huang, Yaruo
Tourette syndrome (TS) is characterized by one of the chronic neuropsychiatric disorders in multiple children, and the pathogenesis of Tourette syndrome (TS) has not been previously elucidated. The aim of this study was designed to investigate the effects of rhynchophylline (RH) on Tourette syndrome (TS) in rats. TS model was established in rats and BV2 cells by the selective 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Behavior evaluations including stereotypy recording and autonomic activity test were performed. Inflammatory cytokine levels such as interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in serum, striatum, and cell supernatant were detected. The expression levels of BDNF/NF-kappa B pathway in striatum and BV2 cells were measured by Western blot. Dopamine (DA) and dopamine receptor D 2 (D2) in striatum were also measured. Data indicated that RH significantly decreased IL-6, IL-1 beta, and TNF-alpha in serum, striatum, and cell supernatant of TS model, with altered expression of P-NF-kappa Bp65, P-I kappa B alpha, and BDNF in TS rats, and DOI-induced BV2 cells, as evidenced by Western blot analysis and immunohistochemistry analysis. RH also significantly reduced the levels of DA and D2 in striatum. Our results shown that the regulation of BDNF/NF-kappa B pathway might be involved in the effects of RH on TS model.